Re: [ccp4bb] Help needed in solving a MAD dataset

2010-05-21 Thread Ulrich Zander
Hi Qing Lu,

try Autorickshaw: http://www.embl-hamburg.de/Auto-Rickshaw/

It can perform the complete structure solution procedure if the quality of
your data is sufficient and I consider it very user-friendly, especially
for beginners .


Regards,


Uli






 Hi All,

 I am new to protein crystallography. I would like to know the steps
 involved
 in solving a MAD dataset by using the program in CCP4 where you determine
 the phases and then obtain the trace. The dataset is collected at 3
 different wavelengths (peak, inflection and remote) using Se-Met as the
 scatterer. The crystals diffracted to resolution of 2 Angstrsoms and has a
 good anomalous signal.

 Thanks,

 Qing Lu



[ccp4bb] Postdoctoral position in protein structure at UCLA

2010-05-21 Thread Todd Yeates
A postdoctoral position is available immediately to work on structures of
bacterial microcompartments and to pursue other projects involving protein
design and assembly.  Bacterial microcompartments are poorly characterized
virus-sized protein shells that serve as organelles inside many bacterial
cells by encapsulating enzymes in key metabolic pathways.  Recent findings
indicate that they are highly sophisticated, for example controlling the
transport of metabolites by specific molecular transport through protein
pores.  Our structural studies on these systems are far enough advanced
that protein design and computational analysis provide numerous avenues
for exploration.  Individuals interested in combining computational
investigations with crystallographic studies are welcome.  UCLA
provides a rich environment for interactive and collaborative work in
structural and computational biology.  Please contact me directly at
yea...@mbi.ucla.edu

Best regards,

Todd Yeates


Re: [ccp4bb] ncsfind

2010-05-21 Thread Clemens Vonrhein
Hi Karin,

I find PROFESSS by Kevin Cowtan very easy to use:

  professs xyzin hatom.pdb xyzout professs.pdb e
  END
  e

I'm sure there is a CCP4i interface for it as well ...

What I especially like about it is the tabulated relation between
sites in the output PDB file.

Cheers

Clemens

On Thu, May 20, 2010 at 04:47:06PM -0600, Karin van Straaten wrote:
 
Dear all,
 
Does anyone know if NCSFIND is still available or how I can get it. If
not is there another program that I can use to determine
noncrystallographic symmetry between Se-sites.
 
Thanks in advance,
 
Karin

-- 

***
* Clemens Vonrhein, Ph.D. vonrhein AT GlobalPhasing DOT com
*
*  Global Phasing Ltd.
*  Sheraton House, Castle Park 
*  Cambridge CB3 0AX, UK
*--
* BUSTER Development Group  (http://www.globalphasing.com)
***


Re: [ccp4bb] TLSANL total B factor question

2010-05-21 Thread Martyn Winn
That was a bug in TLSANL, introduced in 6.1.0 and fixed in 6.1.2. 
So you need to update your CCP4, or at least extract a newer tlsanl
binary. Apologies for that.

Martyn

On Fri, 2010-05-21 at 04:46 +0100, Shiva Kumar wrote:
 Dear Crystallographers
 
 I am trying to  print out my total B factors using TLSANL (version: 6.1) in 
 CCP4- 6.1.1.   My TLSANL’s input file.pdb is coming from refmac (version: 
 5.5.0072) using the TLS  restraint refinement option and isotropic B 
 factors. The TLSANL’s output file.pdb contains the following ATOM and ANISOU 
 records as an example.
 
 REMARK   3  TLS DETAILS
 REMARK   3   NUMBER OF TLS GROUPS  :2
 REMARK   3   ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B FACTORS
 REMARK   3   ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U FACTORS
 
 ATOM 88  C   ASN A  14   0.748  -5.841  -6.258  1.00 35.84   C
 ANISOU   88  C   ASN A  14 5335   4549   3734  0  0  0   C
 ATOM 89  O   ASN A  14   0.807  -6.941  -6.845  1.00 35.04   O
 ANISOU   89  O   ASN A  14 5229   4375   3709  0  0  0   O
 
 
 I am not able to understand why my ANISOU record contains ‘0 0 0’ for the 
 anisotropic component.  Something is not correct and I'm not sure why I am 
 not able to print out my total B factors.
 
 I would appreciate it if someone could tell me what is going wrong and how 
 can I print my total B factors.
 
 
 Thanks
 Regards
 Shiva Kumar
-- 
***
* *
*   Dr. Martyn Winn   *
* *
*   STFC Daresbury Laboratory, Daresbury, Warrington, WA4 4AD, U.K.   *
*   Tel: +44 1925 603455E-mail: martyn.w...@stfc.ac.uk*
*   Fax: +44 1925 603634Skype name: martyn.winn   * 
* URL: http://www.ccp4.ac.uk/martyn/  *
***


Re: [ccp4bb] Help needed in solving a MAD dataset

2010-05-21 Thread Santosh Panjikar

Dear All,
   Not only for beginners, but also for experts who want to solve   
structures in hurry at the beamline and who want to complete model  
starting from X-ray data at resolution better than 3.0 A resolution.


Santosh

Quoting Ulrich Zander ulrich.zan...@strubio.uni-kiel.de:


Hi Qing Lu,

try Autorickshaw: http://www.embl-hamburg.de/Auto-Rickshaw/

It can perform the complete structure solution procedure if the quality of
your data is sufficient and I consider it very user-friendly, especially
for beginners .


Regards,


Uli







Hi All,

I am new to protein crystallography. I would like to know the steps
involved
in solving a MAD dataset by using the program in CCP4 where you determine
the phases and then obtain the trace. The dataset is collected at 3
different wavelengths (peak, inflection and remote) using Se-Met as the
scatterer. The crystals diffracted to resolution of 2 Angstrsoms and has a
good anomalous signal.

Thanks,

Qing Lu







Santosh Panjikar, Ph.D.
Staff Scientist
EMBL-Hamburg Outstation
C/o DESY
Notkestrasse 85
22603 Hamburg (Germany)
panjikar at embl-hamburg.de
http://www.embl-hamburg.de/~panjikar


Re: [ccp4bb] Help needed in solving a MAD dataset

2010-05-21 Thread Gerard Bricogne
Dear Jürgen,

 The road to perfection is a long one ... . Thank you for the feedback!
 
 
 With best wishes,
 
  Gerard.

--
On Thu, May 20, 2010 at 10:31:37PM -0400, Jürgen Bosch wrote:
 I don't like the site finding option in autosharp, takes too long in most of 
 my cases.
 So my approach is locate sites via SHELX, then feed them into Sharp.
 
 Sorry Gerard :-)
 
 Jürgen
 
 On May 20, 2010, at 10:02 PM, Jeremiah Farelli wrote:
 
  I second autoSHARP/SHARP.  It makes great initial maps, and once you get it 
  running, it is totally worth it. 
 
 -
 Jürgen Bosch
 Johns Hopkins Bloomberg School of Public Health
 Department of Biochemistry  Molecular Biology
 Johns Hopkins Malaria Research Institute
 615 North Wolfe Street, W8708
 Baltimore, MD 21205
 Phone: +1-410-614-4742
 Lab:  +1-410-614-4894
 Fax:  +1-410-955-3655
 http://web.mac.com/bosch_lab/
 

-- 

 ===
 * *
 * Gerard Bricogne g...@globalphasing.com  *
 * *
 * Global Phasing Ltd. *
 * Sheraton House, Castle Park Tel: +44-(0)1223-353033 *
 * Cambridge CB3 0AX, UK   Fax: +44-(0)1223-366889 *
 * *
 ===


[ccp4bb] molecular replacement

2010-05-21 Thread intekhab alam
Hi all
I am trying to do molecular replacement with low resolution (4Å) using
Molrep and Phaser.

Overall R-factor is 11.3%, completeness 95.4%, I/sigma 2, and Chi^2 0.95.

Identities between my protein and templates were more than 80%.

I couldn’t get correct solution.

Rotation function, translation score, and contrast were low, and they had no
significance, though I changed the range of resolution.

Molrep suggested solution coordinates clashed with symmetry molecules.

I tried MR after remove clashed regions, but another clashes happened.

In the case of phaser, there were many clashes, too.

Please, give me any suggestion.
Should I concern about any options when I run MR programs?

Hope you guys will be interested to answer!!
Thanks in advance


-- 
INTEKHAB ALAM
LABORATORY OF STRUCTURAL BIOINFORMATICS
KOREA UNIVERSITY, SEOUL


Re: [ccp4bb] molecular replacement

2010-05-21 Thread Tim Gruene
Dear  intekhab,

a few suggestions:
- are you sure of the space group or might there be alternatives?
- is you protein globular or modular, i.e., is it worth running MR with stable
  subdomains one after the other?
- try a poly-alanine model (e.g. chainsaw can do this for you, pdbset probably,
  too)
- did you get overloads? If so, collect a low resolution pass to get correct
  intensities even at the poor resolution end.
- what is your low resolution limit? Did you use the default or could you extend
  it?
- did your crystal(s) suffer from radiation damage? It might be worth collection
  only a complete data set with not too high multiplicity.

Good luck, Tim

On Fri, May 21, 2010 at 08:01:10PM +0900, intekhab alam wrote:
 Hi all
 I am trying to do molecular replacement with low resolution (4Å) using
 Molrep and Phaser.
 
 Overall R-factor is 11.3%, completeness 95.4%, I/sigma 2, and Chi^2 0.95.
 
 Identities between my protein and templates were more than 80%.
 
 I couldn’t get correct solution.
 
 Rotation function, translation score, and contrast were low, and they had no
 significance, though I changed the range of resolution.
 
 Molrep suggested solution coordinates clashed with symmetry molecules.
 
 I tried MR after remove clashed regions, but another clashes happened.
 
 In the case of phaser, there were many clashes, too.
 
 Please, give me any suggestion.
 Should I concern about any options when I run MR programs?
 
 Hope you guys will be interested to answer!!
 Thanks in advance
 
 
 -- 
 INTEKHAB ALAM
 LABORATORY OF STRUCTURAL BIOINFORMATICS
 KOREA UNIVERSITY, SEOUL

-- 
--
Tim Gruene
Institut fuer anorganische Chemie
Tammannstr. 4
D-37077 Goettingen

GPG Key ID = A46BEE1A



signature.asc
Description: Digital signature


Re: [ccp4bb] Question: Refmac5 stats reported in pdb REMARK 3

2010-05-21 Thread Christine Zardecki

Dear Phil,

Your observation that the refinement details in PDB format REMARKs  
are difficult to interpret and compare is well taken. Each refinement  
package produces its own set of refinement results calculated in its  
own way. Both the calculation and presentation of this information in  
PDB format differs between programs, and even between program  
versions. The lack of standardization in how refinement information  
is reported is confusing to many PDB users.


In the spirit of supporting innovation, the PDB has historically  
tried to accommodate this diversity by providing program- and version- 
specific REMARK 3 formats.  However, the field of structural biology  
has matured considerably in the past few decades, and time-tested,  
consensus, and best-practice approaches can now be defined in many  
cases. In our view, adopting such approaches (rather than  
accomodating every variant ever implemented) would be the best way to  
serve the interests of both non-expert user communities and the  
experimental structural biology community.


As an illustration, it is interesting to note that there are at least  
20 different types of R-values reported in the current archive. The  
subtle differences in these quantities may be of interest in  
understanding the evolution of refinement methodology. However, we  
believe that a smaller, common set of well-defined data items  
describing refinement results would be more useful to the broader  
community of PDB users.


To this end, the wwPDB maintains an Exchange Data Dictionary of  
community-vetted definitions and examples of each data item in the  
PDB archive. This is an extensible dictionary that grows with new  
technologies and science. For instance, wwPDB has used this  
extensibility to capture and define all the various R-values. While  
the dictionary technology provides a framework for definition and  
standardization, this only addresses part of the problem.


Even though we have precise definitions for the wide range of R-value  
types, R-value comparisons  between entries is still complicated  
because the values are not uniformly populated across the archive. To  
fully address the problem, we not only need the standardization  
provided by the dictionary technology but also the cooperation of the  
software package developers in producing a common set of statistics  
and diagnostics. This does not preclude reporting new and novel data  
items, but these should be provided in addition to a common core of  
data results.


Further information about the PDB Exchange Data Dictionary can be  
found at our dictionary resource site, http://mmcif.pdb.org/


Correspondence information between our PDB Exchange Data Dictionary  
and items in the current PDB format is also available at

http://mmcif.pdb.org/dictionaries/pdb-correspondence/pdb2mmcif-2010.html

Sincerely,

Christine Zardecki
for the wwPDB




From: Phil Jeffrey pjeff...@princeton.edu
Date: May 19, 2010 4:02:22 PM EDT
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] Question: Refmac5 stats reported in pdb REMARK 3
Reply-To: Phil Jeffrey pjeff...@princeton.edu



Compare these two lines from phenix.refine:
REMARK   3   NUMBER OF REFLECTIONS : 46001
REMARK   3   FREE R VALUE TEST SET COUNT  : 2339

with those from refmac, ostensibly using the same data and start pdb:
REMARK   3   NUMBER OF REFLECTIONS :   43672
REMARK   3   FREE R VALUE TEST SET COUNT  :  2339


I know there are 46011 reflections with |F|0 in the files I used.
phenix.refine removes 10 of these as outliers.  The 46001 remaining  
reported in REMARK 3 *include* the test set.


With REFMAC, 43672+2339=46011 so it appears that Refmac reports  
just the *working* set count in that first line, excluding the test  
set.


Is this is a bug with one program or the other, or a bug in the PDB  
definition of REMARK 3 ? http://www.wwpdb.org/documentation/ 
format23/remark3.html


This appears to be a source of inconsistency.

phenix.refine 1.6-289
refmac5 5.4.0077  (I'm apparently a Luddite)

Phil Jeffrey
Princeton





[ccp4bb] off-topic--refrigerated shakers

2010-05-21 Thread Patrick Loll
Any recommendations for WELL-MADE refrigerated shakers?  Our 1980-vintage New 
Brunswick Psycrotherm*  is getting creaky, and the repair people claim that 
parts are not available. Hence, we're looking at the cost-effectiveness of 
replacing it with a new one. 

Probably best to reply off-list, and I can assemble a summary if appropriate. 
Thanks,
Pat


* yes, it's that lovely shade of harvest gold

---
Patrick J. Loll, Ph. D.  
Professor of Biochemistry  Molecular Biology
Director, Biochemistry Graduate Program
Drexel University College of Medicine
Room 10-102 New College Building
245 N. 15th St., Mailstop 497
Philadelphia, PA  19102-1192  USA

(215) 762-7706
pat.l...@drexelmed.edu


Re: [ccp4bb] molecular replacement

2010-05-21 Thread Vineet Gaur
Also check if you have correctly estimated no. of molecules in asymmetric
unit.

On Fri, May 21, 2010 at 4:58 PM, Tim Gruene t...@shelx.uni-ac.gwdg.de wrote:

 Dear  intekhab,

 a few suggestions:
 - are you sure of the space group or might there be alternatives?
 - is you protein globular or modular, i.e., is it worth running MR with
 stable
  subdomains one after the other?
 - try a poly-alanine model (e.g. chainsaw can do this for you, pdbset
 probably,
  too)
 - did you get overloads? If so, collect a low resolution pass to get
 correct
  intensities even at the poor resolution end.
 - what is your low resolution limit? Did you use the default or could you
 extend
  it?
 - did your crystal(s) suffer from radiation damage? It might be worth
 collection
  only a complete data set with not too high multiplicity.

 Good luck, Tim

 On Fri, May 21, 2010 at 08:01:10PM +0900, intekhab alam wrote:
  Hi all
  I am trying to do molecular replacement with low resolution (4Å) using
  Molrep and Phaser.
 
  Overall R-factor is 11.3%, completeness 95.4%, I/sigma 2, and Chi^2 0.95.
 
  Identities between my protein and templates were more than 80%.
 
  I couldn’t get correct solution.
 
  Rotation function, translation score, and contrast were low, and they had
 no
  significance, though I changed the range of resolution.
 
  Molrep suggested solution coordinates clashed with symmetry molecules.
 
  I tried MR after remove clashed regions, but another clashes happened.
 
  In the case of phaser, there were many clashes, too.
 
  Please, give me any suggestion.
  Should I concern about any options when I run MR programs?
 
  Hope you guys will be interested to answer!!
  Thanks in advance
 
 
  --
  INTEKHAB ALAM
  LABORATORY OF STRUCTURAL BIOINFORMATICS
  KOREA UNIVERSITY, SEOUL

 --
 --
 Tim Gruene
 Institut fuer anorganische Chemie
 Tammannstr. 4
 D-37077 Goettingen

 GPG Key ID = A46BEE1A


 -BEGIN PGP SIGNATURE-
 Version: GnuPG v1.4.9 (GNU/Linux)

 iD8DBQFL9m5wUxlJ7aRr7hoRAnJRAJkBglzDPgqcJ07lOf8wLpGTornFyACeMxwB
 XCPdN9n9Km6Gdn2SK+jv8WY=
 =ncth
 -END PGP SIGNATURE-




[ccp4bb] Alignment software

2010-05-21 Thread Salameh, Mohd A., Ph.D.
Dear All,
I'm trying to prepare an alignment figure of 2 proteins that highlight
conserved and similar residues and probably secondary structures; I will
greatly appreciate it if anybody can recommend a software that I can
use. Thanks, Mohd


Re: [ccp4bb] For 24 well Netxal plates (non ccp4 question) == SUMMARY

2010-05-21 Thread Mathews, Irimpan I.
Dear All,

Thank you for the several responses. Please see the summary below.

1. Several of them:  complain to Qiagen (two or three said: protests loudly).  
Unfortunately, my e-mail to the Qiagen marketing manager never got any reply. I 
e-mailed to him on 5-12-10. Let me know if you need his e-mail address.

2.  Molecular dimensions has the following new item. 

a novel 96 well version of a screw top plate for hanging drop which is of 
standard 96 well plate size.
Please see
http://www.moleculardimensions.com/shopdisplayproducts.asp?id=54cat=Hanging
+drop+

Kind regards,
Mathews


-Original Message-
From: CCP4 bulletin board [mailto:ccp...@jiscmail.ac.uk] On Behalf Of Mathews, 
Irimpan I.
Sent: Tuesday, May 11, 2010 12:41 PM
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] For 24 well Netxal plates (non ccp4 question)

Dear All,

Qiagen has stopped selling the 24 well Netxal trays and changed to 15 well 
trays (almost same price) that doesn't fit with any screens. Do you know of 
some source for the 24 well screw cap trays? 

Thank you very much for your help,
Mathews


Re: [ccp4bb] molecular replacement

2010-05-21 Thread Phoebe Rice
I may be a pessimist, but I'd focus my efforts on getting
experimental phases.  It can be hard to tell a correct
molecular replacement solution from garbage with that kind of
data, and it can be a real time sink because its hard to know
when to quit.
If you can get an SeMet data set, even it it doesn't provide
enough phasing power to crack the problem, you can use the
positions of Se peaks in anomalous diff maps to check possible
molecular replacement solutions.
  Good luck!
Phoebe Rice

 Original message 
Date: Fri, 21 May 2010 20:23:23 +0530
From: Vineet Gaur vineetgaur1...@gmail.com  
Subject: Re: [ccp4bb] molecular replacement  
To: CCP4BB@JISCMAIL.AC.UK

   Also check if you have correctly estimated no. of
   molecules in asymmetric unit.

   On Fri, May 21, 2010 at 4:58 PM, Tim Gruene
   t...@shelx.uni-ac.gwdg.de wrote:

 Dear  intekhab,

 a few suggestions:
 - are you sure of the space group or might there
 be alternatives?
 - is you protein globular or modular, i.e., is it
 worth running MR with stable
  subdomains one after the other?
 - try a poly-alanine model (e.g. chainsaw can do
 this for you, pdbset probably,
  too)
 - did you get overloads? If so, collect a low
 resolution pass to get correct
  intensities even at the poor resolution end.
 - what is your low resolution limit? Did you use
 the default or could you extend
  it?
 - did your crystal(s) suffer from radiation
 damage? It might be worth collection
  only a complete data set with not too high
 multiplicity.

 Good luck, Tim
 On Fri, May 21, 2010 at 08:01:10PM +0900, intekhab
 alam wrote:
  Hi all
  I am trying to do molecular replacement with low
 resolution (4Å) using
  Molrep and Phaser.
 
  Overall R-factor is 11.3%, completeness 95.4%,
 I/sigma 2, and Chi^2 0.95.
 
  Identities between my protein and templates were
 more than 80%.
 
  I couldn’t get correct solution.
 
  Rotation function, translation score, and
 contrast were low, and they had no
  significance, though I changed the range of
 resolution.
 
  Molrep suggested solution coordinates clashed
 with symmetry molecules.
 
  I tried MR after remove clashed regions, but
 another clashes happened.
 
  In the case of phaser, there were many clashes,
 too.
 
  Please, give me any suggestion.
  Should I concern about any options when I run MR
 programs?
 
  Hope you guys will be interested to answer!!
  Thanks in advance
 
 
  --
  INTEKHAB ALAM
  LABORATORY OF STRUCTURAL BIOINFORMATICS
  KOREA UNIVERSITY, SEOUL

 --
 --
 Tim Gruene
 Institut fuer anorganische Chemie
 Tammannstr. 4
 D-37077 Goettingen

 GPG Key ID = A46BEE1A

 -BEGIN PGP SIGNATURE-
 Version: GnuPG v1.4.9 (GNU/Linux)


iD8DBQFL9m5wUxlJ7aRr7hoRAnJRAJkBglzDPgqcJ07lOf8wLpGTornFyACeMxwB
 XCPdN9n9Km6Gdn2SK+jv8WY=
 =ncth
 -END PGP SIGNATURE-
Phoebe A. Rice
Assoc. Prof., Dept. of Biochemistry  Molecular Biology
The University of Chicago
phone 773 834 1723
http://bmb.bsd.uchicago.edu/Faculty_and_Research/01_Faculty/01_Faculty_Alphabetically.php?faculty_id=123

RNA is really nifty
DNA is over fifty
We have put them 
  both in one book
Please do take a 
  really good look
http://www.rsc.org/shop/books/2008/9780854042722.asp


Re: [ccp4bb] Alignment software

2010-05-21 Thread gauri misra
Try ESPript..

Gauri


Re: [ccp4bb] electron microscopy: where open access fails

2010-05-21 Thread Cathy Lawson
Dear Filip, CCP4BB, 3DEM, and PDB-L list members,

Thank you for your enthusiastic showing of community support for mandatory 
deposition of cryoEM maps to EMDB and for their timely release.

The two year hold is available to EMDB depositors for just one practical 
reason:  it encourages deposition of maps that we would probably otherwise not 
be getting at all (and those experiments would thus never be falsifiable).  
Until journals and major funding agencies make deposition and immediate release 
mandatory, we have to compromise.   A large number of petition signatures ( 
http://www.petitiononline.com/cryoEM/petition.html ) will certainly help us to 
solidify our case. 

It is easy to forget that it was not until 1989 (17 years after the PDB began 
collecting X-ray structures) that community-set guidelines were published for 
X-ray crystallography coordinate deposition, and several more years before the 
journals required deposition as a prerequisite for publication.  Structure 
factor deposition only became mandatory in 2008. These policies emerged from 
cooperative action by the community of experimentalists and interestingly 
included a petition that was led by Fred Richards. The same process will be 
effective for the EM community.

Sincerely,

The EMDataBank.org team
http://emdatabank.org


Re: [ccp4bb] Is it possible to mutate a reversible epimerase into an inreversible one?

2010-05-21 Thread James Stroud


On May 20, 2010, at 1:39 PM, Lijun Liu wrote:

I think this is somehow tortured, especially by a quick reading of  
Dale's explanation.



If I understand what you are saying, I think it is too.

You imply that asymmetry in the enzyme results in two isomerase  
pathways. This may be true, but it has no consequence on the prospects  
for irreversibility. To avoid confusion, let's call these pathways D  
and S. Both the D and S pathways would have their own kf and kr  
kinetic constants such that kf_D/kr_D = kr_S/kf_S = Keq, which  
reflects the dG of the reaction. When the dG is close to zero for the  
isomerase reaction (which I assume here), then you can't make it  
irreversible.


James


All natural epimerases, isomerase and racemases use a mechanism  
based on L-amino acids to deal with a mirror-symmetric (quasi-,  
sometimes) reaction.  In another word, these enzymes use a non- 
mirror symmetric structure to deal with a mirror-symmetric reaction,  
which itself causes the asymmetric kinetics for different direction,  
though the dG is 0.  The Arrhenius Law k = A*exp(-dE/RT) should be  
understood like this: a mutation's effect to dE will be symmetric as  
Dale pointed out.  However, the effects on A are asymmetric.   A is  
related to intramolecular diffusion, substrate- and product-binding  
affinity, etc.  That is why with mutation these enzymes changed  
their kinetics on two directions differently.  Please check  
glutamate racemase, alanine racemase, aspartate racemase, DAPE  
epimerase, if you are interested.  Never a 1000 to 1000 relation!


Thus, mutation is possible to make one direction more favored---the  
point is you need the correct hit.  Of course, such an experiment is  
never a Maxwell's demon.


Lijun




On May 19, 2010, at 8:51 AM, Maia Cherney wrote:


You absolutely right, I thought about it.

Maia

Marius Schmidt wrote:

Interestingly, Maxwell's demon pops up here, wh... ,
don't do it.





If you change the reaction rate in one direction 1000  times slower
than
in the other direction, then the reaction becomes practically
irreversible. And the system might not be at equilibrium.

Maia

R. M. Garavito wrote:


Vinson,

As Dale and Randy pointed out, you cannot change the #916G of a  
reaction
by mutation: enzyme, which is a catalyst, affects only the  
activation
barrier (#916E double-dagger).  You can just make it a better  
(or

worse) catalyst which would allow the reaction to flow faster (or
slower) towards equilibrium.  Nature solves this problem very
elegantly by taking a readily reversible enzyme, like an  
epimerase or
isomerase, and coupling it to a much less reversible reaction  
which

removes product quickly.  Hence, the mass action is only in one
direction.  An example of such an arrangement is the triose  
phosphate

isomerase (TIM)-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
reaction pair.  TIM is readily reversible (DHA = G3P), but G3P  
is
rapidly converted to 1,3-diphosphoglycerate by GAPDH.   The  
oxidation

and phosphorylation reactions of GAPDH now make TIM work in one
direction.

Since many epimerases are very optimized enzymes, why not consider
making a fusion with a second enzyme (like a reductase) to make  
the

system flow in one direction.  Of course, this depends on what you
want to do with the product.

Cheers,

Michael

//
/R. Michael Garavito, Ph.D./
/Professor of Biochemistry  Molecular Biology/
/513 Biochemistry Bldg.   /
/Michigan State University  /
/East Lansing, MI 48824-1319/
/Office://  //(517) 355-9724 Lab:  (517) 353-9125/
/FAX:  (517) 353-9334Email:  rmgarav...@gmail.com
mailto:garav...@gmail.com/
//



On May 18, 2010, at 11:54 AM, Dale Tronrud wrote:



Hi,

 I'm more of a Fourier coefficient kind of guy, but I thought  
that a
#916G of zero simply corresponded to an equilibrium constant  
of one.  You
can certainly have reversible reactions with other equilibrium  
constants.
In fact I think irreversible reactions are simply ones where  
the

equilibrium constant is so far to one side that, in practice, the
reaction
always goes all the way to product.

 As Randy pointed out the enzyme cannot change the #916G (or the
equilibrium
constant).  You could drive a reaction out of equilibrium by  
coupling it
to some other reaction which itself is way out of equilibrium  
(such as
ATP hydrolysis in the cell) but I don't think that's a simple  
mutation of

your enzyme.  ;-)

Dale Tronrud

On 05/18/10 00:31, Vinson LIANG wrote:


Dear all,

Sorry for this silly biochemistory question.  Thing is that I  
have a
reversible epimerase and I want to mutate it into an  
inreversible one.
However, I have been told that the #916G of a reversible  
reaction is zero.
Which direction the reaction goes depends only on the  
concentration of

the substrate.  So the conclusion is,

A: I can mutate the 

Re: [ccp4bb] TLSANL total B factor question

2010-05-21 Thread Miller, Mitchell D.
Hi Shiva,
  Not directly related to the problem you reported, but I wanted
to warn you that in refmac 5.5.0072 the default is for the keyword
TLSD WATERS ADD 
to be applied.  This keyword tells refmac to assign all of
your water molecules to existing TLS groups.  (It does this quietly
without any notice as to which waters are assigned to which 
groups in the TLS header of the pdb, TLSOUT or to the log file
and no listing of the default setting of this keyword in the logfile.)
So unless you included the non-default keyword
TLSD WATERS EXCLUDE
then your waters have residual B's as well in your pdb file
and TLSANL cannot convert them to full B's since it has no
record of which waters belong to which TLS groups.  Thus the
output from TLSANL will be a file with mixed full (on protein
atoms) and residual (on water atoms) B-factors.
  If you did not give the keyword TLSD WATERS EXCLUDE, then
the only method I know to ensure that the B-factors on the waters
are properly converted to full-B is to re-run your last refmac job
and add the keyword 
TLSO ADDU
which will give you full B's on your output. (Note that you should
not use this file for input into another round of refmac refinement
-- unless you do a B-factor reset first).

Regards,
Mitch


-Original Message-
From: CCP4 bulletin board [mailto:ccp...@jiscmail.ac.uk] On Behalf Of Shiva 
Kumar
Sent: Thursday, May 20, 2010 8:46 PM
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] TLSANL total B factor question

Dear Crystallographers

I am trying to  print out my total B factors using TLSANL (version: 6.1) in 
CCP4- 6.1.1.   My TLSANL’s input file.pdb is coming from refmac (version: 
5.5.0072) using the TLS  restraint refinement option and isotropic B factors. 
The TLSANL’s output file.pdb contains the following ATOM and ANISOU records as 
an example.

REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  :2
REMARK   3   ATOM RECORD CONTAINS SUM OF TLS AND RESIDUAL B FACTORS
REMARK   3   ANISOU RECORD CONTAINS SUM OF TLS AND RESIDUAL U FACTORS

ATOM 88  C   ASN A  14   0.748  -5.841  -6.258  1.00 35.84   C
ANISOU   88  C   ASN A  14 5335   4549   3734  0  0  0   C
ATOM 89  O   ASN A  14   0.807  -6.941  -6.845  1.00 35.04   O
ANISOU   89  O   ASN A  14 5229   4375   3709  0  0  0   O


I am not able to understand why my ANISOU record contains ‘0 0 0’ for the 
anisotropic component.  Something is not correct and I'm not sure why I am not 
able to print out my total B factors.

I would appreciate it if someone could tell me what is going wrong and how can 
I print my total B factors.


Thanks
Regards
Shiva Kumar


Re: [ccp4bb] Is it possible to mutate a reversible epimerase into an inreversible one?

2010-05-21 Thread Lijun Liu

If I understand what you are saying, I think it is too.

You imply that asymmetry in the enzyme results in two isomerase  
pathways. This may be true, but it has no consequence on the  
prospects for irreversibility. To avoid confusion, let's call these  
pathways D and S. Both the D and S pathways would have their  
own kf and kr kinetic constants such that kf_D/kr_D = kr_S/kf_S =  
Keq, which reflects the dG of the reaction. When the dG is close to  
zero for the
isomerase reaction (which I assume here), then you can't make it  
irreversible.


This is not the case, at least in part.  Such kind of enzymes, if no  
cofactor-needed, use the identical intermediate for the mirror  
symmetric reaction.  For the D -- Intermediate -- S reaction, the  
enzyme uses the same pathway.  Enzymes, for example, glutamate  
racemase and aspartate racemase, use a kind of psudo-mirror symmetric  
alignment at the active site to adapt the binding of D or S isomer in  
the half A.S., respectively.  Other 3 atoms associated to the chiral  
center keeps fixed relative conformation during the inversion.


Standard dG(0) of such a reaction is 0.  However, at the time when  
enzyme works (for example, cell needs D-ASP in an almost pure L-ASP  
environment), the racemase moves L-Asp to D-Asp, in this regard, the  
dG of the reaction (not standard) is not 0.


Your last sentence means:  for a reaction (assuming dG(0) = 0 like  
racemic reaction) almost reaches EQ (dG ~ 0), you cannot make it  
irreversiblethis is true.   Just please do not forget: such kind  
of enzymes work when the D -- S EQ is highly broken by nature (dG   
0) [not dG(0)].


Hopefully I explained clearly!

Lijun




James


All natural epimerases, isomerase and racemases use a mechanism  
based on L-amino acids to deal with a mirror-symmetric (quasi-,  
sometimes) reaction.  In another word, these enzymes use a non- 
mirror symmetric structure to deal with a mirror-symmetric  
reaction, which itself causes the asymmetric kinetics for different  
direction, though the dG is 0.  The Arrhenius Law k = A*exp(-dE/RT)  
should be understood like this: a mutation's effect to dE will be  
symmetric as Dale pointed out.  However, the effects on A are  
asymmetric.   A is related to intramolecular diffusion, substrate-  
and product-binding affinity, etc.  That is why with mutation these  
enzymes changed their kinetics on two directions differently.   
Please check glutamate racemase, alanine racemase, aspartate  
racemase, DAPE epimerase, if you are interested.  Never a 1000 to  
1000 relation!


Thus, mutation is possible to make one direction more favored---the  
point is you need the correct hit.  Of course, such an experiment  
is never a Maxwell's demon.


Lijun




On May 19, 2010, at 8:51 AM, Maia Cherney wrote:


You absolutely right, I thought about it.

Maia

Marius Schmidt wrote:

Interestingly, Maxwell's demon pops up here, wh... ,
don't do it.




If you change the reaction rate in one direction 1000  times  
slower

than
in the other direction, then the reaction becomes practically
irreversible. And the system might not be at equilibrium.

Maia

R. M. Garavito wrote:


Vinson,

As Dale and Randy pointed out, you cannot change the #916G of  
a reaction
by mutation: enzyme, which is a catalyst, affects only the  
activation
barrier (#916E double-dagger).  You can just make it a  
better (or

worse) catalyst which would allow the reaction to flow faster (or
slower) towards equilibrium.  Nature solves this problem very
elegantly by taking a readily reversible enzyme, like an  
epimerase or
isomerase, and coupling it to a much less reversible reaction  
which

removes product quickly.  Hence, the mass action is only in one
direction.  An example of such an arrangement is the triose  
phosphate

isomerase (TIM)-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
reaction pair.  TIM is readily reversible (DHA = G3P), but  
G3P is
rapidly converted to 1,3-diphosphoglycerate by GAPDH.   The  
oxidation

and phosphorylation reactions of GAPDH now make TIM work in one
direction.

Since many epimerases are very optimized enzymes, why not  
consider
making a fusion with a second enzyme (like a reductase) to make  
the
system flow in one direction.  Of course, this depends on what  
you

want to do with the product.

Cheers,

Michael

/ 
/

/R. Michael Garavito, Ph.D./
/Professor of Biochemistry  Molecular Biology/
/513 Biochemistry Bldg.   /
/Michigan State University  /
/East Lansing, MI 48824-1319/
/Office://  //(517) 355-9724 Lab:  (517) 353-9125/
/FAX:  (517) 353-9334Email:  rmgarav...@gmail.com
mailto:garav...@gmail.com/
/ 
/




On May 18, 2010, at 11:54 AM, Dale Tronrud wrote:



Hi,

 I'm more of a Fourier coefficient kind of guy, but I thought  
that a
#916G of zero simply corresponded to an 

Re: [ccp4bb] Is it possible to mutate a reversible epimerase into an inreversible one?

2010-05-21 Thread Dale Tronrud
   I think we are having a problem with the definition of reversible
and irreversible.  By Lijun's definition the reaction is irreversible
because it proceeds from far from equilibrium toward equilibrium.  That
situation is more a property of the system than the enzyme.  If you make
the enzyme 1000 times faster the reaction will proceed more quickly toward
equilibrium despite the fact that the reverse reaction is also 1000 times
faster.  The reverse reaction doesn't matter when there is no product to
act upon.

  The original question was about having a reversible epimerase and I
want to mutate it into an inreversible(sic) one.  Clearly the poster
is talking about a property of the enzyme.  I interpreted this question
to be a request to differentially change the forward and backward reaction
rates, but I could be mistaken.  Maybe the original poster could clarify
the question.

Dale Tronrud

On 05/21/10 13:53, Lijun Liu wrote:
 If I understand what you are saying, I think it is too.

 You imply that asymmetry in the enzyme results in two isomerase
 pathways. This may be true, but it has no consequence on the prospects
 for irreversibility. To avoid confusion, let's call these pathways D
 and S. Both the D and S pathways would have their own kf and kr
 kinetic constants such that kf_D/kr_D = kr_S/kf_S = Keq, which
 reflects the dG of the reaction. When the dG is close to zero for the 
 isomerase reaction (which I assume here), then you can't make it
 irreversible.
 
 This is not the case, at least in part.  Such kind of enzymes, if no
 cofactor-needed, use the identical intermediate for the mirror symmetric
 reaction.  For the D -- Intermediate -- S reaction, the enzyme uses
 the same pathway.  Enzymes, for example, glutamate racemase and
 aspartate racemase, use a kind of psudo-mirror symmetric alignment at
 the active site to adapt the binding of D or S isomer in the half A.S.,
 respectively.  Other 3 atoms associated to the chiral center keeps fixed
 relative conformation during the inversion.
 
 Standard dG(0) of such a reaction is 0.  However, at the time when
 enzyme works (for example, cell needs D-ASP in an almost pure L-ASP
 environment), the racemase moves L-Asp to D-Asp, in this regard, the dG
 of the reaction (not standard) is not 0.
 
 Your last sentence means:  for a reaction (assuming dG(0) = 0 like
 racemic reaction) almost reaches EQ (dG ~ 0), you cannot make it
 irreversiblethis is true.   Just please do not forget: such kind of
 enzymes work when the D -- S EQ is highly broken by nature (dG  0)
 [not dG(0)].
 
 Hopefully I explained clearly!
 
 Lijun
 
 

 James


 All natural epimerases, isomerase and racemases use a mechanism based
 on L-amino acids to deal with a mirror-symmetric (quasi-, sometimes)
 reaction.  In another word, these enzymes use a non-mirror symmetric
 structure to deal with a mirror-symmetric reaction, which itself
 causes the asymmetric kinetics for different direction, though the dG
 is 0.  The Arrhenius Law k = A*exp(-dE/RT) should be understood like
 this: a mutation's effect to dE will be symmetric as Dale pointed
 out.  However, the effects on A are asymmetric.   A is related to
 intramolecular diffusion, substrate- and product-binding affinity,
 etc.  That is why with mutation these enzymes changed their kinetics
 on two directions differently.  Please check glutamate racemase,
 alanine racemase, aspartate racemase, DAPE epimerase, if you are
 interested.  Never a 1000 to 1000 relation!

 Thus, mutation is possible to make one direction more favored---the
 point is you need the correct hit.  Of course, such an experiment is
 never a Maxwell's demon.

 Lijun




 On May 19, 2010, at 8:51 AM, Maia Cherney wrote:

 You absolutely right, I thought about it.

 Maia

 Marius Schmidt wrote:
 Interestingly, Maxwell's demon pops up here, wh... ,
 don't do it.




 If you change the reaction rate in one direction 1000  times slower
 than
 in the other direction, then the reaction becomes practically
 irreversible. And the system might not be at equilibrium.

 Maia

 R. M. Garavito wrote:

 Vinson,

 As Dale and Randy pointed out, you cannot change the #916G of a
 reaction
 by mutation: enzyme, which is a catalyst, affects only the
 activation
 barrier (#916E double-dagger).  You can just make it a better (or
 worse) catalyst which would allow the reaction to flow faster (or
 slower) towards equilibrium.  Nature solves this problem very
 elegantly by taking a readily reversible enzyme, like an
 epimerase or
 isomerase, and coupling it to a much less reversible reaction which
 removes product quickly.  Hence, the mass action is only in one
 direction.  An example of such an arrangement is the triose
 phosphate
 isomerase (TIM)-glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
 reaction pair.  TIM is readily reversible (DHA = G3P), but G3P is
 rapidly converted to 1,3-diphosphoglycerate by GAPDH.   The
 oxidation
 and phosphorylation reactions of 

[ccp4bb] Fwd: calculate the real space R factor using OVERLAPMAP

2010-05-21 Thread Athanasios Dousis

Hello all,

I'm forwarding a question from my labmate Hailiang Zhang regarding 
OVERLAPMAP and real-space R factors.


Thanks in advance for your suggestions.

Nasos Dousis
Rice University

P.S. Can someone please add haili...@bcm.tmc.edu to the CCP4BB listserv?

 Original Message 
Subject:calculate the real space R factor using OVERLAPMAP
Date:   Fri, 21 May 2010 17:48:47 -0500
From:   Zhang, Hailiang haili...@bcm.tmc.edu
To: ndou...@rice.edu ndou...@rice.edu



Hi,

I wanted to calculate the real space R factor using OVERLAPMAP. According to 
the general definition of real space R value 
(http://reference.iucr.org/dictionary/Real-space_residual), everything should 
be absolute value in the formula. However, the results by OVERLAPMAP were 
giving massive negative values. I also checked OVERLAPMAP documentation and 
found that the absolute sign seems absent in the R factor formula 
)http://smb.slac.stanford.edu/facilities/software/ccp4/html/overlapmap.html). I 
was just wondering whether there is some other tools in eg CCP4, Phenix or CNS 
to calculate real-space R in the general way in absolute values.

Thanks!



Re: [ccp4bb] Fwd: calculate the real space R factor using OVERLAPMAP

2010-05-21 Thread Pavel Afonine

Hello,


I was just wondering whether there is some other tools in eg CCP4, Phenix or 
CNS to calculate real-space R in the general way in absolute values.
  


related to your question: in PHENIX you can get a table of map CC 
(computed between model and 2mFo-DFc maps), and the value of mFo-DFc and 
2mFo-DFc maps at atomic centers (in sigmas), along with occupancies and 
B-factors. This can be reported per residue or per atom. The real-space 
R-factor is not computed - well, firstly, no-one asked for this feature 
(I can add it if really wanted), secondly, it feels to me that the 
triplet of values {map CC, 2mFo-DFc, mFo-DFc} is more than enough, and 
also I'm not sure I know how to interpret the real-space R-factor -:)


Tools to get this:

- from PHENIX GUI: Comprehensive validation
- from the command line:

phenix.model_vs_data model.pdb data.mtz

or

phenix.real_space_correlation parameters.par

Let me know if you have any questions about the above programs.

Pavel.


[ccp4bb]

2010-05-21 Thread ruheng

Dear all,

 

Recently, I am working on a complex which includes two protein subunits. The 
interaction was based on the Zinc Finger motif of one protein. I co-purified 
the complex by nickel affinity column with one protein bearing a C terminal His 
tag and the other without any affinity tags. However, the complex was 
disassociated when applied to size exclusion chromatography. The buffer I use 
for SEC is 20mM Tris-HCl, 150mM NaCl, 1mM DTT, 5% Glycerol, pH 7.5, whearas the 
buffer I use for nickel affinity column is 50mM Na2HPO4, 10mM KH2PO4, 137mM 
NaCl, 2.7mM KCl, 10% Glycerol, pH7.4. So I am wondering is it possible for the 
Tris buffer to strip the Zn ions from the Zinc Finger motif of one protein that 
leads to the destruction of the complex?

 

I will be very appreciated if anyone has some experience in such case and would 
like to share with me!

 

 

Sincerely,

 

Heng

 

 

Institute of Biophysics,

Chinese Academy of Sciences,

Beijing 100101, China
  
_
想知道明天天气如何?必应告诉你!
http://cn.bing.com/search?q=%E5%A4%A9%E6%B0%94%E9%A2%84%E6%8A%A5form=MICHJ2

[ccp4bb] Is it possible for the Tris buffer to strip the Zn ions from the Zinc Finger motif of a protein?

2010-05-21 Thread ruheng


 


Date: Sat, 22 May 2010 11:17:41 +0800
From: rh_ibp2...@hotmail.com
Subject: [ccp4bb]
To: CCP4BB@JISCMAIL.AC.UK



Dear all,
 
Recently, I am working on a complex which includes two protein subunits. The 
interaction was based on the Zinc Finger motif of one protein. I co-purified 
the complex by nickel affinity column with one protein bearing a C terminal His 
tag and the other without any affinity tags. However, the complex was 
disassociated when applied to size exclusion chromatography. The buffer I use 
for SEC is 20mM Tris-HCl, 150mM NaCl, 1mM DTT, 5% Glycerol, pH 7.5, whearas the 
buffer I use for nickel affinity column is 50mM Na2HPO4, 10mM KH2PO4, 137mM 
NaCl, 2.7mM KCl, 10% Glycerol, pH7.4. So I am wondering is it possible for the 
Tris buffer to strip the Zn ions from the Zinc Finger motif of one protein that 
leads to the destruction of the complex?
 
I will be very appreciated if anyone has some experience in such case and would 
like to share with me!
 
 
Sincerely,
 
Heng
 
 
Institute of Biophysics,
Chinese Academy of Sciences,
Beijing 100101, China



搜索本应是彩色的,快来体验新一代搜索引擎-必应,精美图片每天换哦! 立即试用! 
  
_
SkyDrive电子画册,带你领略精彩照片,分享“美”时“美”刻!
http://www.windowslive.cn/campaigns/e-magazine/ngmchina/?a=c

Re: [ccp4bb] Is it possible to mutate a reversible epimerase into an inreversible one?

2010-05-21 Thread Vinson LIANG
Dear, Dale, Lijun, Michael and all, 
 
Thank you all very much for your comment and discussion, from which not only do 
I find the answer to my question, but also I have learned a lot. 
 
In my case, both substrates are in the same form, saying 'D'. And I don't 
expect extra energy to break the EQ of the reaction. So I think the best thing 
I could do is to take Mickael's suggestion and add another enzyme to change the 
concentration of one substrate. 
 
However, Lijun's comment do open my mind. 
 
I really appreciate all your help, 
 
Best Regards, 
 
Vinson Liang 


--- 10年5月22日,周六, Dale Tronrud det...@uoxray.uoregon.edu 写道:


发件人: Dale Tronrud det...@uoxray.uoregon.edu
主题: Re: [ccp4bb] Is it possible to mutate a reversible epimerase into an 
inreversible one?
收件人: CCP4BB@JISCMAIL.AC.UK
日期: 2010年5月22日,周六,上午6:38


   I think we are having a problem with the definition of reversible
and irreversible.  By Lijun's definition the reaction is irreversible
because it proceeds from far from equilibrium toward equilibrium.  That
situation is more a property of the system than the enzyme.  If you make
the enzyme 1000 times faster the reaction will proceed more quickly toward
equilibrium despite the fact that the reverse reaction is also 1000 times
faster.  The reverse reaction doesn't matter when there is no product to
act upon.

  The original question was about having a reversible epimerase and I
want to mutate it into an inreversible(sic) one.  Clearly the poster
is talking about a property of the enzyme.  I interpreted this question
to be a request to differentially change the forward and backward reaction
rates, but I could be mistaken.  Maybe the original poster could clarify
the question.

Dale Tronrud

On 05/21/10 13:53, Lijun Liu wrote:
 If I understand what you are saying, I think it is too.

 You imply that asymmetry in the enzyme results in two isomerase
 pathways. This may be true, but it has no consequence on the prospects
 for irreversibility. To avoid confusion, let's call these pathways D
 and S. Both the D and S pathways would have their own kf and kr
 kinetic constants such that kf_D/kr_D = kr_S/kf_S = Keq, which
 reflects the dG of the reaction. When the dG is close to zero for the 
 isomerase reaction (which I assume here), then you can't make it
 irreversible.
 锛濓紳锛濓紳锛濓紳锛濓紳锛濓紳锛濓紳锛濓紳锛濓紳
 This is not the case, at least in part.  Such kind of enzymes, if no
 cofactor-needed, use the identical intermediate for the mirror symmetric
 reaction.  For the D -- Intermediate -- S reaction, the enzyme uses
 the same pathway.  Enzymes, for example, glutamate racemase and
 aspartate racemase, use a kind of psudo-mirror symmetric alignment at
 the active site to adapt the binding of D or S isomer in the half A.S.,
 respectively.  Other 3 atoms associated to the chiral center keeps fixed
 relative conformation during the inversion.
 
 Standard dG(0) of such a reaction is 0.  However, at the time when
 enzyme works (for example, cell needs D-ASP in an almost pure L-ASP
 environment), the racemase moves L-Asp to D-Asp, in this regard, the dG
 of the reaction (not standard) is not 0.
 
 Your last sentence means:  for a reaction (assuming dG(0) = 0 like
 racemic reaction) almost reaches EQ (dG ~ 0), you cannot make it
 irreversiblethis is true.   Just please do not forget: such kind of
 enzymes work when the D -- S EQ is highly broken by nature (dG  0)
 [not dG(0)].
 
 Hopefully I explained clearly!
 
 Lijun
 
 

 James


 All natural epimerases, isomerase and racemases use a mechanism based
 on L-amino acids to deal with a mirror-symmetric (quasi-, sometimes)
 reaction.  In another word, these enzymes use a non-mirror symmetric
 structure to deal with a mirror-symmetric reaction, which itself
 causes the asymmetric kinetics for different direction, though the dG
 is 0.  The Arrhenius Law k = A*exp(-dE/RT) should be understood like
 this: a mutation's effect to dE will be symmetric as Dale pointed
 out.  However, the effects on A are asymmetric.   A is related to
 intramolecular diffusion, substrate- and product-binding affinity,
 etc.  That is why with mutation these enzymes changed their kinetics
 on two directions differently.  Please check glutamate racemase,
 alanine racemase, aspartate racemase, DAPE epimerase, if you are
 interested.  Never a 1000 to 1000 relation!

 Thus, mutation is possible to make one direction more favored---the
 point is you need the correct hit.  Of course, such an experiment is
 never a Maxwell's demon.

 Lijun




 On May 19, 2010, at 8:51 AM, Maia Cherney wrote:

 You absolutely right, I thought about it.

 Maia

 Marius Schmidt wrote:
 Interestingly, Maxwell's demon pops up here, wh... ,
 don't do it.




 If you change the reaction rate in one direction 1000  times slower
 than
 in the other direction, then the reaction becomes practically
 irreversible. And the system might not be at equilibrium.

 Maia

 R. M. Garavito wrote:

 Vinson,

 As Dale and Randy pointed